More on LOVFF
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.34 |
|
|||
| Open | $1.37 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $1.37 | ||||
| Day Low | $1.36 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 15,900 | ||||
- Cannara Announces Graduation to the Toronto Stock Exchange
- Cannara to Host Investor Webcast on February 19th, 2026
- Cannara Biotech raises C$6.3 million in private placement at premium
- Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced at C$2.10 per Common Share
- Cannara Announces Conditional Approval to List on the Toronto Stock Exchange
- Cannara Reports Q1 Fiscal 2026 Results, Delivers New Record Financial Results, Extends Market Share Gains and Advances Disciplined Expansion Strategy
- Cannara Achieves OTCQX Qualification and Announces Release of Fiscal Q1 2026 Financial Results on January 26, 2026
- Cannara Achieves #1 Market Share Position in Québec as of December 2025 and Provides Update on Québec Vape Category Launch
- Cannara Biotech Delivers Record Fiscal 2025 Revenue and Profitability, Achieves First Year of Positive Retained Earnings
- Cannara Biotech Inc. to Announce Fiscal Q4 2025 and Fiscal Year 2025 Financial Results on November 24, 2025 and Provides Board Update
Entities mentioned with LOVFF
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- CIBC | View Related Stories »
- ARK | View Related Stories »
- Canaccord Genuity | View Related Stories »
- Raymond James | View Related Stories »
- BMO Capital | View Related Stories »
- Cowen & Co | View Related Stories »
- Show More...
